These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 20302582)

  • 41. Tacalcitol ointment for long-term control of chronic plaque psoriasis in dermatological practice.
    Lambert J; Trompke C
    Dermatology; 2002; 204(4):321-4. PubMed ID: 12077538
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Topical tacrolimus is effective for facial lesions of psoriasis.
    Yamamoto T; Nishioka K
    Acta Derm Venereol; 2000; 80(6):451. PubMed ID: 11243645
    [No Abstract]   [Full Text] [Related]  

  • 43. Rheological properties of three different vitamin D ointments and their clinical perception by patients with mild to moderate psoriasis.
    Marty JP; Lafforgue C; Grossiord JL; Soto P
    J Eur Acad Dermatol Venereol; 2005 Nov; 19 Suppl 3():7-10. PubMed ID: 16274405
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term treatment of psoriasis with calcipotriol scalp solution and cream.
    Barnes L; Altmeyer P; Fôrstrôm L; Stenström MH
    Eur J Dermatol; 2000; 10(3):199-204. PubMed ID: 10725818
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combination of calcipotriol and clobetasol propionate as a premixed ointment for the treatment of psoriasis.
    Katoh N; Kishimoto S
    Eur J Dermatol; 2003; 13(4):382-4. PubMed ID: 12948920
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Current experience with tacalcitol ointment in the treatment of psoriasis.
    Gollnick H; Menke T
    Curr Med Res Opin; 1998; 14(4):213-8. PubMed ID: 9891193
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Classification of facial psoriasis based on the distributions of facial lesions.
    Woo SM; Choi JW; Yoon HS; Jo SJ; Youn JI
    J Am Acad Dermatol; 2008 Jun; 58(6):959-63. PubMed ID: 18359126
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005% betamethasone dipropionate 0.064% ointment for the treatment of moderate to severe plaque psoriasis.
    Menter A; Abramovits W; Colón LE; Johnson LA; Gottschalk RW
    J Drugs Dermatol; 2009 Jan; 8(1):52-7. PubMed ID: 19180896
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tacalcitol: A useful adjunct to narrow band ultraviolet B phototherapy in psoriasis.
    Aggarwal P; Aggarwal K; Jain VK
    J Dermatolog Treat; 2016 Nov; 27(6):546-551. PubMed ID: 27052200
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Iatrogenic hypercalcemia due to vitamin D3 ointment (1,24(OH)2D3) combined with thiazide diuretics in a case of psoriasis.
    Kawaguchi M; Mitsuhashi Y; Kondo S
    J Dermatol; 2003 Nov; 30(11):801-4. PubMed ID: 14684937
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Proven efficacy of tacrolimus for facial and intertriginous psoriasis.
    Lebwohl M; Freeman A; Chapman MS; Feldman S; Hartle J; Henning A
    Arch Dermatol; 2005 Sep; 141(9):1154. PubMed ID: 16172314
    [No Abstract]   [Full Text] [Related]  

  • 52. Topical calcipotriol (MC 903) for psoriasis: a clinical study.
    Mozzanica N; Cattaneo A; Schmitt E; Legori A; Finzi AF
    Acta Derm Venereol Suppl (Stockh); 1994; 186():169-70. PubMed ID: 8073826
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Placebo-controlled evaluation of the irritant potential of tacalcitol (1a,24-dihydroxyvitamin D3) in healthy volunteers.
    Schlotmann K; Ortland C; Neumann NJ; Ruzicka T; Lehmann P
    Contact Dermatitis; 2000 May; 42(5):260-3. PubMed ID: 10789839
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clobetasol propionate for psoriasis: are ointments really more potent?
    Warino L; Balkrishnan R; Feldman SR
    J Drugs Dermatol; 2006 Jun; 5(6):527-32. PubMed ID: 16774104
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy and safety of topical calcitriol (1,25-dihydroxyvitamin d3) for the treatment of psoriasis.
    Pèrez A; Chen TC; Turner A; Raab R; Bhawan J; Poche P; Holick MF
    Br J Dermatol; 1996 Feb; 134(2):238-46. PubMed ID: 8746336
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Are ointments better than other vehicles for corticosteroid treatment of psoriasis?
    Zivkovich AH; Feldman SR
    J Drugs Dermatol; 2009 Jun; 8(6):570-2. PubMed ID: 19537382
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tacalcitol and narrow-band phototherapy in patients with vitiligo.
    Leone G; Pacifico A; Iacovelli P; Paro Vidolin A; Picardo M
    Clin Exp Dermatol; 2006 Mar; 31(2):200-5. PubMed ID: 16487090
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Calcipotriol ointment versus cream in psoriasis vulgaris.
    Duweb G; Aldebani S; Elzorghany A; Benghazil M; Alhaddar J
    Int J Clin Pharmacol Res; 2003; 23(2-3):47-51. PubMed ID: 15018018
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clobetasol propionate followed by calcipotriol is superior to calcipotriol alone in topical treatment of psoriasis.
    Austad J; Bjerke JR; Gjertsen BT; Helland S; Livden JK; Morken T; Mørk NJ
    J Eur Acad Dermatol Venereol; 1998 Jul; 11(1):19-24. PubMed ID: 9731961
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.
    Jemec GB; Ganslandt C; Ortonne JP; Poulin Y; Burden AD; de Unamuno P; Berne B; Figueiredo A; Austad J
    J Am Acad Dermatol; 2008 Sep; 59(3):455-63. PubMed ID: 18694678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.